bioRxivPharmacology & Toxicology
A Model Mechanism Based Explanation of an In Vitro-In Vivo Disconnect for Improving Extrapolation and Translation
Abstract
An improved understanding of in vivo-to-in vitro hepatocyte changes is crucial to interpreting in vitro data correctly and further improving hepatocyte-based in vitro-to-in vivo extrapolations to human targets. We demonstrate using virtual experiments as a means to help untangle plausible causes of inaccurate extrapolations. We start with virtual mice that have biomimetic software livers. Earlier, using those mice, we discovered model mechanisms that enabled achieving quantitative validation targets while also providing plausible causal explanations for temporal characteristics of acetaminophen hepatotoxicity. We isolated virtual hepatocytes, created a virtual culture, and then conducted dose-response experiments in both culture and mice. We expected the two dose-response curves to be displaced. We were surprised that they crossed because it evidenced that simulated acetaminophen metabolism and toxicity are different for virtual culture and mouse contexts even though individual hepatocyte mechanisms were unchanged. Crossing dose-response curves is a virtual example of an in vivo-to-in vitro disconnect. We use detailed results of experiments to explain the disconnect. Individual hepatocytes contribute differently to system level phenomena. In liver, hepatocytes are exposed to acetaminophen sequentially. Relative production of the reactive acetaminophen metabolite is largest (smallest) in pericentral (periportal) hepatocytes. Because that sequential exposure is absent in culture, hepatocytes from different lobular locations do not respond the same. A virtual Culture-to-Mouse translation can stand as a scientifically challengeable theory explaining an in vitro-in vivo disconnect. It provides a framework to develop more reliable interpretations of in vitro observations, which then may be used to improve extrapolations.\n\nAbbreviations
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Utilizing virtual experiments to increase understanding of discrepancies involving in vitro-in vivo predictions of hepatic clearance
P. Krishnan, A. K. Smith, … C. A. Hunt·bioRxiv·Oct 9, 2020
- Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms
A. K. Smith, G. E. P. Ropella, … C. A. Hunt·bioRxiv·Dec 24, 2019
- Differences between in vivo and ex vivo models drive divergent perturbation outcomes
Aarathy Ravi Sundar Jose Geetha, Cynthia del Valle, … Nikolaus Fortelny·bioRxiv·Sep 2, 2025
- A machine learning liver-on-a-chip system for safer drug formulation
Y. Shi, C.-H. Lin, … G. Traverso·bioRxiv·Sep 5, 2022
- In silico predictions of the hepatic metabolic clearance in humans for 10 drugs with highly variable in vitro pharmacokinetics
U. Fagerholm·bioRxiv·Apr 1, 2023
- Utilising an in silico model to predict outcomes in senescence-driven acute liver injury
C. Ashmore-Harris, E. Antonopoulou, … S. L. Waters·bioRxiv·Oct 11, 2023